H. Lundbeck, Solvay Pharmaceuticals and Wyeth sign development and marketing agreement for bifeprunox in the USA

Lundbeck’s partner Solvay Pharmaceuticals, B.V. and Wyeth Pharmaceuticals today announced a development and marketing agreement for bifeprunox in the USA, Mexico, Japan and Canada.